Tech

搜索文档
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
Prnewswire· 2025-07-22 07:00
NEW YORK, July 21, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 15, 2025.So What: If you purchased Capricor securities during the ...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of iTeos Therapeutics, Inc.
Prnewswire· 2025-07-22 06:00
NEW YORK, July 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by iTeos Therapeutics, Inc. (NASDAQ: ITOS) and its board of directors concerning the proposed acquisition of the company by Concentra Biosciences, LLC. Stockholders will receive $10.047 and one contingent value right for each share of iTeos Therapeutics stock that they hold. The transaction is expected to close in the third quarter of 2025.If you are a stockholder of iTeos Therapeutics, Inc. and are ...
Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings
Seeking Alpha· 2025-07-22 05:20
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?I have covered Evolus (NASDAQ: EOLS ) twice before in notes for Seeking Alpha, the first time in March 2024 , issuing a "Buy" recommendation, and re-iterating that rating in a more recent note, inThe group is for b ...
Lost Money on DoubleVerify Holdings, Inc.(DV)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm
GlobeNewswire News Room· 2025-07-22 04:32
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DoubleVerify Holdings, Inc. (NYSE: DV). Shareholders who purchased shares of DV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/doubleverify-holdings-inc-loss-submission-form-2/?id=157195&from=3 CLASS PER ...
Class Action Filed Against PepGen Inc. (PEPG) Seeking Recovery for Investors – Contact The Gross Law Firm
GlobeNewswire News Room· 2025-07-22 04:32
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG). Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pepgen-inc-loss-submission-form/?id=157194&from=3 CLASS PERIOD: March 7, 2024 to March ...
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights – CAPR
GlobeNewswire News Room· 2025-07-22 04:30
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/capricor-loss-submission-form/?id=157205&from=3 CLASS PERIOD: October ...
Health In Tech Announces Second Quarter 2025 Financial Results
Prnewswire· 2025-07-22 04:30
Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024. Adjusted EBITDA of $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2 times full year 2024. Cash balance of $8.1 million.STUART, Fla. , July 21, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the second quarter ended June 30, 2025.Financial Highlights for ...
Lost Money on Biohaven Ltd. (BHVN)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm
GlobeNewswire News Room· 2025-07-22 04:30
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN). Shareholders who purchased shares of BHVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=157193&from=3 CLASS PERIOD: March 24, 2023 to Ma ...
reAlpha Tech Corp. Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Globenewswire· 2025-07-22 04:30
DUBLIN, Ohio, July 21, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced that it has entered into definitive agreements for the purchase and sale of 14,285,718 shares of its common stock at a purchase price of $0.35 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 14,285,718 sha ...
Shareholders that lost money on Sarepta Therapeutics, Inc.(SRPT) should contact The Gross Law Firm about pending Class Action - SRPT
GlobeNewswire News Room· 2025-07-22 04:27
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Shareholders who purchased shares of SRPT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/sarepta-loss-submission-form/?id=157188&from=3 CLASS PERIOD: June 22, 2 ...